Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway mucus disulfide bonds are covalent linkages formed between cysteine residues on mucin glycoproteins, primarily MUC5AC and MUC5B. These bonds are critical for the viscoelastic properties of mucus, enabling pathogen trapping and mucociliary clearance. Pathological increase in disulfide cross-linking, driven by oxidative stress, contributes to muco-obstructive lung diseases. Therapeutic targeting aims to reduce these bonds to decrease mucus viscosity, but selectivity is crucial to avoid disrupting normal host defense mechanisms.
Disruption of disulfide bonds, decreasing mucus viscosity and elasticity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway Mucus Disulfide Bonds.